Targeting mitochondrial oxidative metabolism in LAM using a first-in-class lipoate analog

Awardee: Carmen Priolo

Institution: Brigham and Women's Hospital, Harvard Medical School

Award Amount: $72,704

Previous
Previous

Defining the cellular site of action of the Glut1 protein in Glucose Transporter 1 deficiency syndrome.

Next
Next

Engineered microvessels derived from human lymphatic endothelium as an in vitro model for drug repurposing for lymphatic malformations